Previous 10 |
home / stock / rammf / rammf news
RAMM Pharma (RAMMF) has commenced commercial sales of its NettaPet cannabidiol (“CBD”) enriched super premium quality dog food.NettaPet is the first product to be commercialized by RAMM’s wholly owned subsidiary NettaLife which focuses on the production, commercialization...
TORONTO, April 09, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) (OTC: RAMMF) , a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that it has commenced co...
Delta, Kelowna, BC - March 25, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insig...
RAMM Pharma (RAMMF) announces that it has initiated clinical trials studying the efficacy of its proprietary NettaVet pet cannabinoid formulation for the treatment of four pathologies in animals.The trials will be conducted in partnership with Universidad de la Republica de Uruguay ...
TORONTO, March 25, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) (OTC: RAMMF) , a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that it has initiated cl...
News, Short Squeeze, Breakout and More Instantly...
RAMM Pharma Company Name:
RAMMF Stock Symbol:
OTCMKTS Market:
Not for Dissemination in the US or through US Newswire Services TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , is providing an update on its dispute with Sergio Martines an...
TORONTO, Nov. 17, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the “...
TORONTO, Sept. 27, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the ȁ...